Andrew D. Kelly

Emergency Medicine Foundation — United States

Biochemistry, Genetics and Molecular Biology · Life Sciences

13h-index948citations59works0.72yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Epigenetics and DNA Methylation(19), Acute Myeloid Leukemia Research(19), Cancer Genomics and Diagnostics(13), Lung Cancer Treatments and Mutations(11), Chronic Myeloid Leukemia Treatments(10)

Publications59 total

Association of a homologous recombination deficiency signature with oncologic outcomes in advanced endometrial cancer
Gynecologic Oncology·2025
Validation of comprehensive genomic profiling for prognostic and potential therapeutic molecular classification of endometrial cancer
International Journal of Gynecological Cancer·2025· 2 citedOpen Access
Exceptional and durable response with pembrolizumab in a patient with microsatellite stable metastatic castrate-resistant prostate cancer: High tumor mutational burden and circulating tumor DNA clearance as predictive biomarkers
Oncology and Translational Medicine·2025· 1 citedOpen Access
Association of high ctDNA tumor fraction (TF) and detection of clinically significant copy number (CN) losses in liquid biopsies (LBx) from patients with advanced prostate cancer (PCa).
Journal of Clinical Oncology·2025
A dynamic microRNA profile that tracks a chemotherapy resistance phenotype in osteosarcoma. Implications for novel therapeutics
2024· 1 citedOpen Access
Endometrial cancer (EC) by ERBB2 amplification (ERBB2amp) status: Differences in molecular subtypes, ancestry, and real-world outcomes.
Journal of Clinical Oncology·2024
Data from TET1-Mediated Hypomethylation Activates Oncogenic Signaling in Triple-Negative Breast Cancer
2023Open Access
Supplementary Figures S1-6, Supplementary Tables S1-3, Supplementary methods from TET1-Mediated Hypomethylation Activates Oncogenic Signaling in Triple-Negative Breast Cancer
2023Open Access
Data from TET1-Mediated Hypomethylation Activates Oncogenic Signaling in Triple-Negative Breast Cancer
2023Open Access
Supplementary Figures S1-6, Supplementary Tables S1-3, Supplementary methods from TET1-Mediated Hypomethylation Activates Oncogenic Signaling in Triple-Negative Breast Cancer
2023Open Access
Biomarker associations of immune checkpoint inhibitor versus chemotherapy effectiveness in first-line metastatic endometrial carcinomas: A real-world study.
Journal of Clinical Oncology·2022
Genome-wide DNA methylation patterns reveal clinically relevant predictive and prognostic subtypes in human osteosarcoma
Communications Biology·2022· 34 citedOpen Access
Pan-cancer landscape of <i>CD274</i> (PD-L1) rearrangements in 283,050 patient samples, its correlation with PD-L1 protein expression, and immunotherapy response
Journal for ImmunoTherapy of Cancer·2021· 16 citedOpen Access
<i>STRN-ALK</i> Fusion–Positive Case of Breast Cancer With Response to Alectinib
JCO Precision Oncology·2021· 3 citedOpen Access
Prevalence of inferred clonal hematopoiesis (CH) detected on comprehensive genomic profiling (CGP) of solid tumor tissue or circulating tumor DNA (ctDNA).
Journal of Clinical Oncology·2021· 13 cited
Incremental analysis of constraint logic programs
Figshare·2021Open Access
Genome-wide DNA methylation patterns reveal clinically relevant predictive and prognostic subtypes in osteosarcoma
2020· 1 citedOpen Access
Machine learning-based prediction of response to PARP inhibition across cancer types
2019· 3 citedOpen Access
Genomic and epigenomic predictors of response to guadecitabine in relapsed/refractory acute myelogenous leukemia
Clinical Epigenetics·2019· 28 citedOpen Access
Additional file 3: of Genomic and epigenomic predictors of response to guadecitabine in relapsed/refractory acute myelogenous leukemia
Figshare·2019Open Access
page 1 of 3Next →

Frequent Co-authors

Jean‐Pierre J. Issa(20), Jaroslav Jelı́nek(17), Dimitrios Spentzos(12), Hagop M. Kantarjian(11), Patricia Kropf(9), Woonbok Chung(8), Gail J. Roboz(8), Benjamin Haibe‐Kains(7), Edwin Choy(7), Henry C. Fung(7), Xiang Yao Su(7), Charly R. Good(6), Jozef Madžo(6), Jeffrey D. Goldsmith(6), John Quackenbush(6), Harald Søndergaard(6), Kim Marriott(6), Peter J. Stuckey(6), Mohammad Azab(6), Katherine E. Hill(5)